Correlation Between Immutep and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immutep and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immutep Ltd ADR and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Immutep and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and Rigel Pharmaceuticals.
Diversification Opportunities for Immutep and Rigel Pharmaceuticals
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Immutep and Rigel is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Immutep i.e., Immutep and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immutep and Rigel Pharmaceuticals
Given the investment horizon of 90 days Immutep is expected to generate 1.96 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, Immutep Ltd ADR is 1.14 times less risky than Rigel Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,230 in Rigel Pharmaceuticals on November 28, 2024 and sell it today you would earn a total of 1,000 from holding Rigel Pharmaceuticals or generate 81.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.37% |
| Values | Daily Returns |
Immutep Ltd ADR vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Immutep Ltd ADR |
| Rigel Pharmaceuticals |
Immutep and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immutep and Rigel Pharmaceuticals
The main advantage of trading using opposite Immutep and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Cidara Therapeutics | Rigel Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |